Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $6.1950 (-4.84%) ($6.1950 - $6.1950) on Wed. Oct. 20, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.46% (three month average) | RSI | 56 | Latest Price | $6.1950(-4.84%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1.1% a day on average for past five trading days. | Weekly Trend | CGEN advances 2% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(71%) ARKG(70%) ARKK(68%) IWO(66%) IBUY(64%) | Factors Impacting CGEN price | CGEN will decline at least -1.73% in a week (0% probabilities). VIXM(-52%) VXX(-37%) UUP(-13%) TLT(-6%) SHY(-2%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.73% (StdDev 3.46%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $6.25 | 5 Day Moving Average | $6.39(-3.05%) | 10 Day Moving Average | $6.35(-2.44%) | 20 Day Moving Average | $6.25(-0.88%) | To recent high | -12.7% | To recent low | 6.6% | Market Cap | $512m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |